Michael Sherling, MD

home / authors / michael-sherling-md

Dr Sherling is a practicing dermatologist as well as chief medical and strategy officer, and cofounder of health care information technology company ModMed.

Articles

Dermatologist Creates AI Tool to Make Documentation Easier

Dermatologist Creates AI Tool to Make Documentation Easier

Michael Sherling, MD;Heidi Anne Duerr, MPH
Published: March 8th 2025 | Updated: March 8th 2025

Michael Sherling, MD, MBA, leverages AI to simplify administrative tasks and focus on patient care.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
Published: February 28th 2025 | Updated: May 8th 2025
POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
Published: January 23rd 2025 | Updated: May 8th 2025
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
The Complex World of Urticaria: Insights from Jason Hawkes, MD, MS
Published: February 13th 2025 | Updated: May 8th 2025
The Complex World of Urticaria: Insights from Jason Hawkes, MD, MS
Q&A: Thomas Casale, MD, Discusses Abstract on Dupilumab and Significant Itch, Hive Reduction in Chronic Spontaneous Urticaria
Published: March 3rd 2025 | Updated: May 8th 2025
Q&A: Thomas Casale, MD, Discusses Abstract on Dupilumab and Significant Itch, Hive Reduction in Chronic Spontaneous Urticaria
Q&A: Jonathan Bernstein, MD, FAAAAI, Discusses Advances in Chronic Spontaneous Urticaria Treatments and AAAAI Data
Published: March 5th 2025 | Updated: May 8th 2025
Q&A: Jonathan Bernstein, MD, FAAAAI, Discusses Advances in Chronic Spontaneous Urticaria Treatments and AAAAI Data
© 2025 MJH Life Sciences

All rights reserved.